| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Colloidal iodine |
Is a |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine isotope |
Is a |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine measurement |
Has measured component |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine-induced hyperthyroidism |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Congenital iodine deficiency syndrome of mixed type |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Congenital iodine deficiency syndrome of neurological type |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine, urine free measurement |
Has measured component |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine adverse reaction (disorder) |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Radioiodine uptake study |
Direct substance |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hyperthyroidism caused by potassium iodide (disorder) |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Goiter due to iodine excess in foals |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hyperthyroidism secondary to radio contrast dyes |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Endemic cretinism |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Contact dermatitis caused by iodine (disorder) |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Iododerma |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine measurement |
Component |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iodine, urine free measurement |
Component |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Iodine 0.7% film forming alcoholic solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodide poisoning (disorder) |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental iodide poisoning |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional iodide poisoning |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodide poisoning of undetermined intent |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodophore adverse reaction |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Povidone iodine adverse reaction |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Ion exchange resin adverse reaction |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cation exchange resin adverse reaction |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cellulose phosphate adverse reaction (disorder) |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Calcium polystyrene sulfonate adverse reaction |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium polystyrene sulphonate adverse reaction |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to iodine compound |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine allergy |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to iodophore (finding) |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to povidone iodine |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine compounds overdose |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodide overdose |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental iodide overdose |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional iodide overdose (disorder) |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodide overdose of undetermined intent |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing iodine AND/OR iodine compound |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aqueous iodine 130mg/mL oral solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| composés iodés |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine weak solution BP (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine strong solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine 37% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine compound |
Is a |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodophore product (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 125mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 408mg/mL + iodine 200mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 408mg/mL + iodine 200mg/mL injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 408mg/mL + iodine 200mg/mL injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 75mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 175mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lipiodol (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing ethiodized oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely potassium iodide 65 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing iodine and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing chlorphenamine and codeine and phenylephrine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Potassium iodide + theophylline, anhydrous 130mg/80mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing potassium iodide and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Potassium iodide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium iodide 118mcg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium iodide 100mcg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine acne |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Potassium iodide 65 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 300mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 180mg + iodine 85mg/mL (18%) injection solution 300mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 2000mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1000mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1250mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental iodide poisoning |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional iodide poisoning |
Causative agent (attribute) |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iodine adverse reaction (disorder) |
Causative agent (attribute) |
True |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 75mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 510mg + iodine 250mg/mL (51%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 510mg + iodine 250mg/mL (51%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 510mg + iodine 250mg/mL (51%) injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 408mg/mL + iodine 200mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iopamidol 510mg + iodine 250mg/mL (51%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]